SVB Leerink raised the price target for the Eli Lilly and Company (NYSE:LLY) stock to ‘an Outperform’. The rating was released on May 23, 2023, according to finviz. We previously noted in another research note published on April 06, 2023 by Morgan Stanley that resumed the stock to an Overweight with a price target of $364 for LLY stock. The research report from Daiwa Securities has initiated the stock to Outperform, with a price target set at $286. The stock was upgraded by DZ Bank, who disclosed in a research note on January 21, 2023, from Hold to Buy and set the price objective to $291.
Would Eli Lilly and Company (LLY) Stock like to attract the attention of traders?
